Synthetic gene networks have evolved from simple proof-of-concept circuits to complex therapy-oriented networks over the past 15 years. This advancement has greatly facilitated the expansion of the emerging field of synthetic biology. In this review, we highlight the main applications of synthetic gene networks in understanding biological design principles, developing biosensors for diagnosis, producing industrial and biomedical compounds, and treating human diseases. Finally, we outline current challenges and future prospects of synthetic gene networks for advancing practical applications.
GardnerT.S., CantorC.R., and CollinsJ.J. (2000) Construction of a genetic toggle switch in Escherichia coli.Nature, 403, 339–342.
7.
ElowitzM.B., and LeiblerS. (2000) A synthetic oscillatory network of transcriptional regulators. Nature, 403, 335–338.
8.
NevozhayD., AdamsR.M., MurphyK.F., JosićK., and BalázsiG. (2009) Negative autoregulation linearizes the dose–response and suppresses the heterogeneity of gene expression. Proc. Natl. Acad. Sci., 106, 5123–5128.
9.
FriedlandA.E. (2009) Synthetic gene networks that count. Science, 324, 1199–1202.
10.
DaninoT., Mondragón-PalominoO., TsimringL., and HastyJ. (2010) A synchronized quorum of genetic clocks. Nature, 463, 326–330.
BasuS., MehrejaR., ThibergeS., ChenM.-T., and WeissR. (2004) Spatiotemporal control of gene expression with pulse-generating networks. Proc. Natl. Acad. Sci. USA, 101, 6355–6360.
WangB., KitneyR.I., JolyN., and BuckM. (2011) Engineering modular and orthogonal genetic logic gates for robust digital-like synthetic biology. Nat. Commun., 2, 508.
15.
SiutiP., YazbekJ., and LuT.K. (2013) Synthetic circuits integrating logic and memory in living cells. Nat. Biotechnol., 31, 448–452.
16.
StantonB.C. (2014) Genomic mining of prokaryotic repressors for orthogonal logic gates. Nat. Chem. Biol., 10, 99–105.
17.
GörkeB., and StülkeJ. (2008) Carbon catabolite repression in bacteria: many ways to make the most out of nutrients. Nat. Rev. Microbiol., 6, 613–624.
18.
GreenA.A., SilverP.A., CollinsJ.J., and YinP. (2014) Toehold switches: de-novo-designed regulators of gene expression. Cell, 159, 925–939.
19.
BashorC.J., HelmanN.C., YanS., and LimW.A. (2008) Using engineered scaffold interactions to reshape MAP kinase pathway signaling dynamics. Science, 319, 1539–1543.
20.
DeansT.L., CantorC.R., and CollinsJ.J. (2007) A tunable genetic switch based on RNAi and repressor proteins for regulating gene expression in mammalian cells. Cell, 130, 363–372.
21.
PadiracA., FujiiT., and RondelezY. (2012) Bottom-up construction of in vitro switchable memories. Proc. Natl. Acad. Sci. USA, 109, E3212–3220.
22.
ChengA.A., and LuT.K. (2012) Synthetic biology: an emerging engineering discipline. Annu. Rev. Biomed. Eng., 14, 155–178.
23.
KarlebachG., and ShamirR. (2008) Modelling and analysis of gene regulatory networks. Nat. Rev. Mol. Cell Biol., 9, 770–780.
24.
MukherjiS., and van OudenaardenA. (2009) Synthetic biology: understanding biological design from synthetic circuits. Nat. Rev. Genet., 10, 859–871.
25.
WuM. (2013) Engineering of regulated stochastic cell fate determination. Proc. Natl. Acad. Sci. USA, 110, 10610–10615.
26.
StrickerJ. (2008) A fast, robust and tunable synthetic gene oscillator. Nature, 456, 516–519.
27.
TiggesM., Marquez-LagoT.T., StellingJ., and FusseneggerM. (2009) A tunable synthetic mammalian oscillator. Nature, 457, 309–312.
WuF., MennD.J., and WangX. (2014) Quorum-sensing crosstalk-driven synthetic circuits: from unimodality to trimodality. Chem. Biol., 21, 1629–1638.
30.
WangB., BarahonaM., and BuckM. (2013) A modular cell-based biosensor using engineered genetic logic circuits to detect and integrate multiple environmental signals. Biosens. Bioelectron., 40, 368–376.
31.
KotulaJ.W. (2014) Programmable bacteria detect and record an environmental signal in the mammalian gut. Proc. Natl. Acad. Sci., 111, 4838–4843.
WuM.-C., LawB., WilkinsonB., and MicklefieldJ. (2012) Bioengineering natural product biosynthetic pathways for therapeutic applications. Curr. Opin. Biotechnol., 23, 931–940.
34.
AtsumiS. (2008) Metabolic engineering of Escherichia coli for 1-butanol production. Metab. Eng., 10, 305–311.
35.
Valle-RodríguezJ.O., ShiS., SiewersV., and NielsenJ. (2014) Metabolic engineering of Saccharomyces cerevisiae for production of fatty acid ethyl esters, an advanced biofuel, by eliminating non-essential fatty acid utilisation pathways. Appl. Energy, 115, 226–232.
36.
SavageD.F., WayJ., and SilverP.A. (2008) Defossiling fuel: how synthetic biology can transform biofuel production. ACS Chem. Biol., 3, 13–16.
37.
Peralta-YahyaP.P., ZhangF., del CardayreS.B., and KeaslingJ.D. (2012) Microbial engineering for the production of advanced biofuels. Nature, 488, 320–328.
38.
RoD.-K. (2006) Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature, 440, 940–943.
39.
PaddonC.J. (2013) High-level semi-synthetic production of the potent antimalarial artemisinin. Nature, 496, 528–532.
40.
RuderW.C., LuT., and CollinsJ.J. (2011) Synthetic biology moving into the clinic. Science, 333, 1248–1252.
41.
NissimL., and Bar-ZivR.H. (2010) A tunable dual-promoter integrator for targeting of cancer cells. Mol. Syst. Biol., 6, 444.
42.
XieZ., WroblewskaL., ProchazkaL., WeissR., and BenensonY. (2011) Multi-input RNAi-based logic circuit for identification of specific cancer cells. Science, 333, 1307–1311.
43.
YeH., BabaM.D.-E., PengR.-W., and FusseneggerM. (2011) A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice. Science, 332, 1565–1568.
44.
RössgerK., Charpin-El-HamriG., and FusseneggerM. (2013) A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice. Nat. Commun., 4, 2825.
45.
YeH. (2013) Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome. Proc. Natl. Acad. Sci., 110, 141–146.
46.
KemmerC. (2010) Self-sufficient control of urate homeostasis in mice by a synthetic circuit. Nat. Biotechnol., 28, 355–360.
47.
ChenY.Y., JensenM.C., and SmolkeC.D. (2010) Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems. Proc. Natl. Acad. Sci., 107, 8531–8536.
48.
WeiP. (2012) Bacterial virulence proteins as tools to rewire kinase pathways in yeast and immune cells. Nature, 488, 384–388.
49.
FauconP.C. (2014) Gene networks of fully connected triads with complete auto-activation enable multistability and stepwise stochastic transitions. PLoS ONE, 9, e102873.
50.
YadavV.G., De MeyM., Giaw LimC., Kumaran AjikumarP., and StephanopoulosG. (2012) The future of metabolic engineering and synthetic biology: towards a systematic practice. Metab. Eng., 14, 233–241.
51.
YeH., AubelD., and FusseneggerM. (2013) Synthetic mammalian gene circuits for biomedical applications. Curr. Opin. Chem. Biol., 17, 910–917.
52.
YeH., and FusseneggerM. (2014) Synthetic therapeutic gene circuits in mammalian cells. FEBS Lett., 588, 2537–2544.
